Podcast

Podcast: This Week in Managed Care—Creating Association Health Plans and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week in managed care, the top stories included Atul Gawande, MD, being named the CEO of the Amazon—Berkshire Hathaway–JPMorgan Chase healthcare venture; the Trump administration finalized rules for creating association health plans; an analysis found some cancer types are represented more than others in the Oncology Care Model.

To listen, login to the website.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Amazon, Berkshire Hathaway, JPMorgan Chase Announce CEO of Joint Health Company

New Rule Allows Creation of Association Health Plans That Skirt ACA Regulations, Protections

Participation in OCM May Transform Care for Certain Cancer Types More Quickly Than Others

Implementing Alternative Payment Models for Improved Population Health: Experiences from the OCM

UpWell Health Survey: 45% of Those With Diabetes Skip Care Due to Costs

A Retrospective on the Oncology Care Model

Perspective: FDA/CMS Parallel Review Advances Coverage for Cancer Comprehensive Genomic Profiling

Evidence-Based Oncology—June 2018

Read more about the stories in this podcast:

Related Videos
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Sandra Cuellar, PharmD
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo